Bing Zhou Selected Research

Bing Zhou Research Topics

Disease

60	Neoplasms (Cancer) 04/2024 - 12/2005
23	Inflammation (Inflammations) 09/2023 - 05/2004
20	Rhinosinusitis 10/2023 - 09/2007
16	Allergic Rhinitis 12/2023 - 04/2003
13	Nasal Polyps (Nasal Polyp) 10/2023 - 05/2003
11	Infections 05/2024 - 07/2008
11	Non-alcoholic Fatty Liver Disease 01/2024 - 07/2017
10	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2014
9	Carcinogenesis 03/2024 - 02/2014
8	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2012
8	Leukemia 03/2024 - 04/2012
8	COVID-19 12/2022 - 01/2020
7	Fatty Liver 12/2023 - 12/2014
6	Malaria 12/2023 - 03/2010
6	Fibrosis (Cirrhosis) 01/2022 - 01/2017
6	Hypersensitivity (Allergy) 01/2021 - 06/2002
5	Insulin Resistance 01/2024 - 01/2017
5	Asthma (Bronchial Asthma) 10/2023 - 05/2004
5	Rheumatoid Arthritis 10/2022 - 03/2014
5	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 01/2012
5	Sinusitis 09/2022 - 05/2004
4	Adenocarcinoma of Lung 01/2023 - 01/2020
4	Hypertension (High Blood Pressure) 10/2022 - 11/2016
4	Body Weight (Weight, Body) 01/2022 - 01/2013
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2021 - 08/2020
4	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2021 - 09/2013
4	Wounds and Injuries (Trauma) 05/2019 - 05/2017
4	Pancreatitis 03/2013 - 04/2009
3	Atrial Fibrillation 11/2023 - 10/2016
3	Osteosarcoma (Osteogenic Sarcoma) 01/2023 - 09/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 05/2005
3	Adenoma (Adenomas) 01/2022 - 04/2012
3	Alcoholic Fatty Liver 01/2022 - 12/2014
3	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 01/2022 - 01/2003
3	Atherosclerosis 01/2022 - 10/2010
3	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 01/2016
3	Ischemic Stroke 12/2021 - 01/2019
3	Parkinson Disease (Parkinson's Disease) 11/2021 - 03/2014
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2021 - 01/2018
3	Hypoxia (Hypoxemia) 05/2021 - 08/2009
3	Carcinoma (Carcinomatosis) 01/2021 - 01/2012
3	Obesity 11/2020 - 01/2019
3	Eosinophilia 08/2013 - 02/2004

Drug/Important Bio-Agent (IBA)

36	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2003
10	Messenger RNA (mRNA)IBA 03/2024 - 11/2004
9	CytokinesIBA 06/2023 - 08/2003
8	EnzymesIBA 03/2024 - 12/2003
8	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 08/2002
8	SteroidsIBA 10/2023 - 11/2004
8	MicroRNAs (MicroRNA)IBA 12/2021 - 08/2014
7	IronIBA 01/2024 - 01/2003
7	Therapeutic UsesIBA 01/2023 - 12/2005
7	Long Noncoding RNAIBA 01/2023 - 01/2014
6	AntibodiesIBA 05/2024 - 07/2014
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2017
6	Immunoglobulin E (IgE)IBA 01/2021 - 06/2002
6	Interleukin-5 (Interleukin 5)IBA 06/2009 - 08/2003
5	snake venom protein C activatorIBA 03/2024 - 08/2018
5	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2019
5	Neutralizing AntibodiesIBA 01/2022 - 07/2014
5	Triglycerides (Triacylglycerol)IBA 01/2022 - 05/2005
5	ZincIBA 12/2016 - 07/2002
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2014 - 12/2003
4	AntigensIBA 05/2024 - 04/2000
4	LipopolysaccharidesIBA 01/2022 - 01/2013
4	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 05/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 09/2005
4	CateninsIBA 09/2019 - 01/2013
4	artemisinin (artemisinine)IBA 01/2017 - 03/2010
4	CeruletideIBA 03/2013 - 04/2009
3	Transcription Factors (Transcription Factor)IBA 03/2024 - 08/2003
3	AntioxidantsIBA 01/2023 - 01/2017
3	6-methyladenineIBA 01/2023 - 01/2021
3	C-Reactive ProteinIBA 01/2023 - 12/2020
3	CopperIBA 10/2022 - 09/2013
3	Angiotensin IIIBA 10/2022 - 09/2016
3	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2014
3	LipidsIBA 01/2022 - 06/2005
3	Monoclonal AntibodiesIBA 01/2022 - 01/2020
3	MethyltransferasesIBA 12/2021 - 01/2019
3	Cadherins (E-Cadherin)IBA 12/2021 - 07/2011
3	Circular RNAIBA 12/2021 - 10/2017
3	MetalsIBA 11/2021 - 06/2007
3	Matrix Metalloproteinases (MMPs)IBA 12/2015 - 08/2002
3	Interleukin-12 (IL 12)IBA 06/2009 - 06/2005
3	AllergensIBA 06/2006 - 03/2005
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2004 - 04/2003
2	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 03/2024 - 10/2022
2	Fluticasone (Cutivate)FDA LinkGeneric 12/2023 - 09/2023
2	Nasal SpraysIBA 12/2023 - 09/2023
2	azelastine (Optivar)FDA LinkGeneric 12/2023 - 09/2023
2	N-methyladenosineIBA 10/2023 - 01/2021
2	FructoseIBA 09/2023 - 01/2021

Therapy/Procedure

33	Therapeutics 11/2023 - 06/2006
5	Stents 10/2023 - 06/2015
4	Immunotherapy 08/2022 - 03/2008
4	Drug Therapy (Chemotherapy) 01/2022 - 02/2014
4	Operative Surgical Procedures 08/2021 - 12/2003
4	Endoscopes 10/2013 - 08/2005
3	Radiotherapy 11/2021 - 06/2019